Skip to main content
. 2020 Mar 18;40(3):BSR20192826. doi: 10.1042/BSR20192826

Figure 2. Isorhamnetin inhibits cell growth and induces LDH release in prostate cancer cell lines.

Figure 2

(A) Effects of Isorhamnetin (2.5, 5, 10, and 20 μM) on the cell growth of DU145 cells. (B) Effects of Isorhamnetin (2.5, 5, 10, and 20 μM) on the cell growth of PC3 cells. (C) Effects of Isorhamnetin (2.5, 5, 10, and 20 μM) on the cell growth of LNCaP cells. (D) Effects of Isorhamnetin (2.5, 5, 10, and 20 μM) on the cell growth of PrEC cells. (E) Effects of Isorhamnetin (5, 10, and 20 μM) on the LDH release of DU145 and PC3 cells. (F) Effects of Isorhamnetin (5, 10, and 20 μM) on the LDH release of LNCaP and PrEC cells. Related data appear as the means ± SD of three separate assays. *P<0.05 and **P<0.01 vs control.